Drugs & Medications

Drug-Induced Musical Hallucinations: Causes & Treatments (2024 Research)

by

Drug-induced musical hallucinations occur across various medical conditions, with antidepressants, opioids, and other medications as common triggers, potentially arising from neurotransmitter imbalances; treatment often involves modifying or discontinuing the trigger drug. Highlights: Prevalence & Demographics: The average patient age was 58.3 years, with 67.9% being female. Common Conditions: Hearing impairments, psychiatric disorders, cancers, and neurodegenerative …

Read more

Intranasal Insulin for Mild Cognitive Impairment: Enhancing Social Skills, Memory, Grey Matter Volume (2024 Case Report)

by

Extended intra-nasal insulin (INI) treatment in an insulin-resistant early Mild Cognitive Impairment (MCI) patient improved grey matter volume, reduced beta-amyloid levels, and enhanced cognitive and pragmatic capacities, suggesting potential to slow neurodegenerative disease progression. Highlights: Grey Matter Volume: After 9 months of INI treatment, the patient experienced an increase in grey matter volume. Beta-Amyloid Levels: …

Read more

Ketamine Rapidly Reverses Suicidal Ideation & Severe Depression (2024 Meta-Analysis)

by

Ketamine significantly reduces suicidal ideation in depressed patients, with rapid effects observed within the first day of treatment. Highlights: Rapid Reduction: Ketamine shows a significant reduction in suicidal ideation within the first day of treatment (RR = 10.02, 95% CI = 4.24 to 23.68). Sustained Improvement: Repeated ketamine treatments result in a greater reduction of …

Read more

Serotonin (5-HT) vs. Tumors & Cancers: Potential Immunomodulation Treatment (2024 Research)

by

Cancer patients frequently experience depressive symptoms, and the role of serotonin in tumor regulation varies across different types. Highlights: Prevalence of Depression in Cancer Patients: A significant portion of cancer patients experience depressive symptoms, which are often linked to neuroendocrine hormone imbalances and decreased serotonin levels. Neuroimmunology’s Role: Neuroimmunology is an emerging field that has …

Read more

PCSK9 Inhibitors May Increase Parkinson’s Disease & Reduce ALS Risk (2024 Study)

by

PCSK9 inhibitors significantly reduce the risk of amyotrophic lateral sclerosis (ALS) but increase the risk of Parkinson’s disease (PD). Highlights: ALS Risk Reduction: PCSK9 inhibitors marginally reduced the risk of ALS with an odds ratio of 0.89 (p = 0.048). PD Risk Increase: PCSK9 inhibitors increased the risk of Parkinson’s disease, with an odds ratio …

Read more

Repurposing General Anesthetic Drugs to Treat Depression: Ketamine, Nitrous Oxide, Propofol, Isoflurane (2024 Research)

by

Repurposing general anesthetic drugs like ketamine for the treatment of major depression represents a significant medical advancement – showcasing rapid and sustained antidepressant effects. Highlights: Rapid Antidepressant Effects: Ketamine, nitrous oxide, propofol, and isoflurane have shown rapid and sustained antidepressant properties, offering new treatment options for major depressive disorder and treatment-resistant depression. Mechanisms of Action: …

Read more

rTMS of Left Dorsolateral Prefrontal Cortex (DL-PFC) May Treat Methamphetamine Addiction via Altering Cravings & Decision Making (2024 Study)

by

Repetitive transcranial magnetic stimulation (rTMS) on the left dorsolateral prefrontal cortex (dlPFC) improves decision-making and reduces cravings in individuals with methamphetamine use disorder (MUD). Highlights: Improved Decision-Making: rTMS treatment enhanced decision-making abilities in MUD patients, making their choices more rational and similar to healthy individuals. Craving Reduction: Participants experienced a significant decrease in cravings for …

Read more

Deep Brain Stimulation (DBS) of Nucleus Accumbens Treats Cocaine Addiction in Male Rats But Not Females (2024 Study)

by

Deep brain stimulation (DBS) in the nucleus accumbens reduces cocaine seeking in male rats but is ineffective in female rats, regardless of their estrous cycle phase. Highlights: No FDA-Approved Treatments: There are currently no FDA-approved treatments for cocaine use disorder. DBS Reduces Cocaine Seeking in Males: Previous studies and the current experiment show that DBS …

Read more

Shexiang Baoxin Pills (SBP) May Reduce Depression & Improve Heart Function via Anti-Inflammatory Effect (2024 Rat Study)

by

Shexiang Baoxin Pills (SBP) may help improve heart function and reduce depression in patients with acute myocardial infarction (AMI) by reducing inflammation. Highlights: Depression & Heart Disease Link: Patients with heart attacks often experience depression, which can worsen their heart condition. Study Purpose: This study tested the effectiveness of SBP, a traditional Chinese medicine, in …

Read more

Allopregnanolone vs. Diazepam: Antidepressant Effects via Brain Activity Modulation (2024 Mouse Study)

by

Allopregnanolone shows antidepressant-like effects in mice by increasing social interaction and specific brain wave activities, unlike diazepam. Highlights: Allopregnanolone: Allopregnanolone, a neuroactive steroid, increases social interaction time in mice experiencing social defeat stress, indicating potential antidepressant-like effects. Brain Activity: This increase in social interaction is associated with heightened theta and beta oscillations in the basolateral …

Read more

+ Load more